The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The clinical objectives/aims of this HPV educational intervention project are to determine: 1. The number of young adults and adolescents in each arm who received any dose of the HPV vaccine during the study period, 2. The number of young adults and adolescents in each arm who initiated the HPV vaccine series during the study period, 3. The number of young adults and adolescents in each arm who initiated but did not complete the HPV vaccine series during the study period, 4. The number of young adults and adolescents in each arm, among all eligible, who completed the HPV vaccine series during the study period, 5. The number of young adults and adolescents in each arm who completed the HPV vaccine series during the study period, among those who initiated the series at study start, and 6. The number of young adults and adolescents in each arm who completed the HPV vaccine series among those who initiated the series during the study period. The implementation of this educational intervention in clinic waiting rooms is intended to assist primary care providers in communicating HPV vaccine awareness and education to parents and patients in a culturally tailored format.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Young Adults Who Received Any Dose of the HPV Vaccine During the Study Period
Timeframe: 16 months
Number of Young Adults Who Initiated the HPV Vaccine Series During the Study Period
Timeframe: 16 months
Number of Young Adults Who Initiated But Did Not Complete the HPV Vaccine Series During the Study Period
Timeframe: 16 months
Number of Young Adults, Among All Eligible, Who Completed the HPV Vaccine Series During the Study Period
Timeframe: 16 months
Number of Young Adults Who Completed the HPV Vaccine Series During the Study Period, Among Those Who Initiated the Series at Study Start
Timeframe: 16 months
Number of Young Adults Who Completed the HPV Vaccine Series Among Those Who Initiated the Series During the Study Period
Timeframe: 16 months
Number of Adolescents Who Received Any Dose of the HPV Vaccine During the Study Period
Timeframe: 16 months
Number of Adolescents Who Initiated the HPV Vaccine Series During the Study Period
Timeframe: 16 months
Number of Adolescents Who Initiated But Did Not Complete the HPV Vaccine Series During the Study Period
Timeframe: 16 months
Number of Adolescents, Among All Eligible, Who Completed the HPV Vaccine Series During the Study Period
Timeframe: 16 months
Number of Adolescents Who Completed the HPV Vaccine Series During the Study Period, Among Those Who Initiated the Series at Study Start
Timeframe: 16 months
Number of Adolescents Who Completed the HPV Vaccine Series Among Those Who Initiated the Series During the Study Period
Timeframe: 16 months